Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Evolving Cybersecurity Demand Consumer Price Index Rises 38 in April Marking Highest Annual Inflation Since May 2023 US SEC Proposes Allowing Public Companies to Skip Quarterly Earnings Reports Stifel Raises Semtech Price Target to 188 Amid Data Center Demand Optimism HighYield Savings Rates Update Up to 41 APY Available as National Average Stands at 038 May 23 2026 JKHY Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Uncertainty TeraWulf Inc WULF Q1 2026 Earnings Massive EPS Miss as Bitcoin Mining Headwinds Persist Hyperfine Inc HYPR Q1 2026 Earnings Narrower Loss Beats Estimates Stock Declines Amid Uncertain Revenue Outlook WidePoint Corporation WYY Q1 2026 Earnings Profitability Beat Drives 11 Stock Surge Ridgepost Capital Inc RPC Q1 2026 Earnings Slight EPS Beat Amid Mixed Signals Stock Slips InMode INMD Rebounds 163 as Shares Find Support Near 1334 Harvard Ave Acquisition HAVA Stock Holds Steady at 1008 as Trading Remains Flat BioAge Labs Inc BIOA Holds Near Support After Minor Decline Key Levels to Watch Estrella Immunopharma ESLA Edges Lower Near Support as Biotech Sector Faces Headwinds ALT5 Sigma Corporation ALTS Holds Steady at 085 as Consolidation Continues Fractyl Health Inc GUTS Declines 27 as Stock Tests Critical Support Near 078 Nvidia Invests Billions in Photonics Startups to Tackle AI Data Transfer Bottleneck BKE Q1 2026 Earnings EPS Beats Estimates Stock Declines 9 Japans Naphtha Concerns Persist Amid Rising US and India Supply Trump Signals No Rush on Iran Nuclear Deal Criticizes Opponents as Losers DOX Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Lower Park Ha Biological Technology BYAH Holds Gains as Stock Tests Key Support Zone AA Q1 2026 Earnings EPS Falls Short of Estimates Shares Rise on Operational Strength Sunrun RUN Q1 2026 Earnings EPS Surges to 062 Crushing Estimates by Over 2600 SPMA Q1 2026 Earnings Preferred Shares Miss EPS Estimates Stock Declines Serve Robotics Inc SERV Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Undisclosed SGHT Q1 2026 Earnings EPS Misses Street Expectations by Over 42 Madrigal Pharmaceuticals MDGL Q1 2026 Earnings NarrowerThanExpected Loss Despite No Reported Revenue Stock Slips OKLO Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued PreRevenue Development